Published in Obstet Gynecol on December 01, 2013
Engineered cationic antimicrobial peptides to overcome multidrug resistance by ESKAPE pathogens. Antimicrob Agents Chemother (2014) 0.91
Factors associated with 30-day hospital readmission after hysterectomy. Obstet Gynecol (2015) 0.80
Prophylactic Antibiotic Choice and Risk of Surgical Site Infection After Hysterectomy. Obstet Gynecol (2016) 0.78
Improving Patient Outcomes in Gynecology: The Role of Large Data Registries and Big Data Analytics. J Minim Invasive Gynecol (2015) 0.77
Antibiotic Prophylaxis for Gynecologic Procedures prior to and during the Utilization of Assisted Reproductive Technologies: A Systematic Review. J Pathog (2016) 0.75
Inappropriate use of antibiotics in patients undergoing gynecologic surgery. Proc (Bayl Univ Med Cent) (2017) 0.75
Adherence to surgical care improvement project measures and the association with postoperative infections. JAMA (2010) 6.89
A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data. Med Care (2009) 5.13
Robotically assisted vs laparoscopic hysterectomy among women with benign gynecologic disease. JAMA (2013) 4.67
Antibiotic therapy and treatment failure in patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease. JAMA (2010) 4.57
Comparative effectiveness of robotic versus laparoscopic hysterectomy for endometrial cancer. J Clin Oncol (2012) 2.59
Evidence-based performance measures: preventing unintended consequences of quality measurement. Ann Intern Med (2011) 2.56
Misdiagnosis of community-acquired pneumonia and inappropriate utilization of antibiotics: side effects of the 4-h antibiotic administration rule. Chest (2007) 2.32
Effects of pay for performance in health care: a systematic review of systematic reviews. Health Policy (2013) 2.32
The surgical infection prevention and surgical care improvement projects: national initiatives to improve outcomes for patients having surgery. Clin Infect Dis (2006) 2.27
Prevention and treatment of surgical site infection: summary of NICE guidance. BMJ (2008) 2.21
Avoiding serious infections associated with abdominal hysterectomy: a meta-analysis of antibiotic prophylaxis. Am J Obstet Gynecol (1993) 2.07
An evaluation of surgical site infections by wound classification system using the ACS-NSQIP. J Surg Res (2011) 1.89
Complications of hysterectomy. Obstet Gynecol (2013) 1.87
Reducing unnecessary inpatient laboratory testing in a teaching hospital. Am J Clin Pathol (2006) 1.79
Antibiotic timing and errors in diagnosing pneumonia. Arch Intern Med (2008) 1.65
Clinical practice guidelines for antimicrobial prophylaxis in surgery. Surg Infect (Larchmt) (2013) 1.60
Effect of surgical volume on outcomes for laparoscopic hysterectomy for benign indications. Obstet Gynecol (2012) 1.58
The effect of surgeon volume on outcomes and resource use for vaginal hysterectomy. Obstet Gynecol (2010) 1.56
Surgical site infection prevention: the importance of operative duration and blood transfusion--results of the first American College of Surgeons-National Surgical Quality Improvement Program Best Practices Initiative. J Am Coll Surg (2008) 1.56
ACOG practice bulletin No. 104: antibiotic prophylaxis for gynecologic procedures. Obstet Gynecol (2009) 1.55
Trends in surgical mesh use for pelvic organ prolapse from 2000 to 2010. Obstet Gynecol (2012) 1.55
Improving surgical site infections: using National Surgical Quality Improvement Program data to institute Surgical Care Improvement Project protocols in improving surgical outcomes. J Am Coll Surg (2010) 1.26
Adherence to surgical care improvement project measures and post-operative surgical site infections. Surg Infect (Larchmt) (2012) 1.23
Quality of perioperative venous thromboembolism prophylaxis in gynecologic surgery. Obstet Gynecol (2011) 1.21
The Surgical Infection Prevention and Surgical Care Improvement Projects: promises and pitfalls. Am Surg (2006) 1.17
Effect of surgical volume on morbidity and mortality of abdominal hysterectomy for endometrial cancer. Obstet Gynecol (2011) 1.14
The role of physicians in controlling medical care costs and reducing waste. JAMA (2011) 1.09
"Reducing unnecessary testing in a CPOE system through implementation of a targeted CDS intervention". BMC Med Inform Decis Mak (2013) 1.09
Hospital costs associated with surgical site infections in general and vascular surgery patients. Surgery (2011) 1.08
Prophylactic antibiotics in abdominal hysterectomy. J Am Coll Surg (1994) 1.03
Feasibility and economic impact of same-day discharge for women who undergo laparoscopic hysterectomy. Am J Obstet Gynecol (2012) 1.01
Antibiotic prophylaxis in gynaecologic procedures. J Obstet Gynaecol Can (2012) 0.98
The influence of surgical volume on morbidity and mortality of radical hysterectomy for cervical cancer. Am J Obstet Gynecol (2011) 0.93
Quality of venous thromboembolism prophylaxis in patients undergoing oncologic surgery. Ann Surg (2011) 0.93
Venous thromboembolism and use of prophylaxis among women undergoing laparoscopic hysterectomy. Obstet Gynecol (2011) 0.92
How to save costs by reducing unnecessary testing: lean thinking in clinical practice. Eur J Intern Med (2011) 0.92
Antibiotic prophylaxis in vaginal hysterectomy: a review. Obstet Gynecol (1980) 0.90
Lessons learned from the institution of the Surgical Care Improvement Project at a teaching medical center. Am J Surg (2009) 0.88
Antibiotic prophylaxis for selected gynecologic surgeries. Int J Gynaecol Obstet (2012) 0.78
Improving value in gynecologic surgery: we can all do better. Obstet Gynecol (2013) 0.78
Epidemiology of gastric cancer. World J Gastroenterol (2006) 7.67
Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group. J Natl Cancer Inst (2009) 5.62
Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy. J Natl Cancer Inst (2007) 4.97
Robotically assisted vs laparoscopic hysterectomy among women with benign gynecologic disease. JAMA (2013) 4.67
Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients. J Clin Oncol (2010) 4.43
Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk. JAMA (2004) 4.31
Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer. J Clin Oncol (2007) 3.92
A proportional hazards model with time-dependent covariates and time-varying effects for analysis of fetal and infant death. Am J Epidemiol (2004) 3.77
Risk of perforation after colonoscopy and sigmoidoscopy: a population-based study. J Natl Cancer Inst (2003) 3.71
Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer. Breast Cancer Res Treat (2010) 3.35
Trabectedin plus pegylated liposomal Doxorubicin in recurrent ovarian cancer. J Clin Oncol (2010) 3.33
Previous cesarean delivery and risks of placenta previa and placental abruption. Obstet Gynecol (2006) 3.08
Racial disparities in treatment and survival among women with early-stage breast cancer. J Clin Oncol (2005) 3.02
High prevalence of vitamin D deficiency despite supplementation in premenopausal women with breast cancer undergoing adjuvant chemotherapy. J Clin Oncol (2009) 2.97
Electronic fetal heart rate monitoring and its relationship to neonatal and infant mortality in the United States. Am J Obstet Gynecol (2011) 2.93
Environmental toxins and breast cancer on Long Island. I. Polycyclic aromatic hydrocarbon DNA adducts. Cancer Epidemiol Biomarkers Prev (2002) 2.83
The impact of suboptimal bowel preparation on adenoma miss rates and the factors associated with early repeat colonoscopy. Gastrointest Endosc (2011) 2.73
The Long Island Breast Cancer Study Project: description of a multi-institutional collaboration to identify environmental risk factors for breast cancer. Breast Cancer Res Treat (2002) 2.71
Racial disparities in utilization of liver transplantation for hepatocellular carcinoma in the United States, 1998-2002. Am J Gastroenterol (2007) 2.69
Does augmentation or induction of labor with oxytocin increase the risk for autism? Am J Obstet Gynecol (2013) 2.68
Evaluation of third-degree and fourth-degree laceration rates as quality indicators. Obstet Gynecol (2015) 2.64
Comparative effectiveness of robotic versus laparoscopic hysterectomy for endometrial cancer. J Clin Oncol (2012) 2.59
Use of the Internet by women with breast cancer. J Med Internet Res (2003) 2.46
Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer. Cancer (2006) 2.36
Gestational diabetes in the United States: temporal trends 1989 through 2004. Am J Obstet Gynecol (2008) 2.36
Comparison of survival outcomes among cancer patients treated in and out of clinical trials. J Natl Cancer Inst (2014) 2.30
Resource utilization for ovarian cancer patients at the end of life: how much is too much? Gynecol Oncol (2005) 2.26
Delay of adjuvant chemotherapy initiation following breast cancer surgery among elderly women. Breast Cancer Res Treat (2006) 2.26
Duration of adjuvant chemotherapy for colon cancer and survival among the elderly. J Clin Oncol (2006) 2.26
Prostate cancer in fathers with fewer male offspring: the Jerusalem Perinatal Study cohort. J Natl Cancer Inst (2007) 2.24
Latest research and treatment of advanced-stage epithelial ovarian cancer. Nat Rev Clin Oncol (2013) 2.24
Trends in relative survival for ovarian cancer from 1975 to 2011. Obstet Gynecol (2015) 2.22
Reconciling the high rates of preterm and postterm birth in the United States. Obstet Gynecol (2007) 2.21
Uptake and economic impact of first-cycle colony-stimulating factor use during adjuvant treatment of breast cancer. J Clin Oncol (2012) 2.21
Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions. Gynecol Oncol (2007) 2.20
Lymphadenectomy influences the utilization of adjuvant radiation treatment for endometrial cancer. Am J Obstet Gynecol (2011) 2.19
Racial disparities for uterine corpus tumors: changes in clinical characteristics and treatment over time. Cancer (2009) 2.15
Chemotherapy and cardiotoxicity in older breast cancer patients: a population-based study. J Clin Oncol (2005) 2.11
Epidemiology of upper gastrointestinal malignancies. Semin Oncol (2004) 2.10
Elevated preoperative neutrophil:lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer. Ann Surg Oncol (2011) 2.10
Surgical-pathological predictors of disease-free survival and risk groupings for IB2 cervical cancer: do the traditional models still apply? Gynecol Oncol (2004) 2.08
Electric blanket use and breast cancer on Long Island. Epidemiology (2003) 2.06
Nationwide trends in the performance of inpatient hysterectomy in the United States. Obstet Gynecol (2013) 2.05
Placental abruption. Obstet Gynecol (2006) 2.05
Socioeconomic and other predictors of colonoscopy preparation quality. Dig Dis Sci (2010) 2.04
Associations between breast cancer risk and the catalase genotype, fruit and vegetable consumption, and supplement use. Am J Epidemiol (2005) 2.03
The role for adjuvant radiotherapy in the treatment of hemangiopericytoma: a Surveillance, Epidemiology, and End Results analysis. J Neurosurg (2013) 2.01
Association between prescription co-payment amount and compliance with adjuvant hormonal therapy in women with early-stage breast cancer. J Clin Oncol (2011) 2.00
Prognostic significance of adenocarcinoma histology in women with cervical cancer. Gynecol Oncol (2012) 1.98
Comparative performance of the 2009 international Federation of gynecology and obstetrics' staging system for uterine corpus cancer. Obstet Gynecol (2010) 1.98
Trends and Predictors of Cerclage Use in the United States From 2005 to 2012. Obstet Gynecol (2015) 1.96
The influence of an audience response system on knowledge retention: an application to resident education. Am J Obstet Gynecol (2005) 1.96
Fear, anxiety, worry, and breast cancer screening behavior: a critical review. Cancer Epidemiol Biomarkers Prev (2004) 1.96
Prophylactic and risk-reducing bilateral salpingo-oophorectomy: recommendations based on risk of ovarian cancer. Obstet Gynecol (2010) 1.94
Survival associated with 5-fluorouracil-based adjuvant chemotherapy among elderly patients with node-positive colon cancer. Ann Intern Med (2002) 1.89
Predictors of massive blood loss in women with placenta accreta. Am J Obstet Gynecol (2011) 1.86
Lifetime alcohol intake and breast cancer risk. Ann Epidemiol (2005) 1.85
Risk of malignancy in patients with celiac disease. Am J Med (2003) 1.85
Prevalence of defective DNA mismatch repair and MSH6 mutation in an unselected series of endometrial cancers. Proc Natl Acad Sci U S A (2003) 1.83
Effect of breast cancer radiotherapy and cigarette smoking on risk of second primary lung cancer. J Clin Oncol (2008) 1.83
Hormone receptor status and survival in a population-based cohort of patients with breast carcinoma. Cancer (2005) 1.78
Delay in initiating adjuvant radiotherapy following breast conservation surgery and its impact on survival. Int J Radiat Oncol Biol Phys (2006) 1.77
Risk factors of abruptio placentae among Peruvian women. Am J Obstet Gynecol (2006) 1.77
Induced Abortions and the Risk of Preeclampsia Among Nulliparous Women. Am J Epidemiol (2015) 1.76
High radical prostatectomy surgical volume is related to lower radical prostatectomy total hospital charges. Eur Urol (2006) 1.76
Adherence to biopsy guidelines for Barrett's esophagus surveillance in the community setting in the United States. Clin Gastroenterol Hepatol (2009) 1.76
Primary therapy for early-stage cervical cancer: radical hysterectomy vs radiation. Am J Obstet Gynecol (2009) 1.75
Weight gain prior to diagnosis and survival from breast cancer. Cancer Epidemiol Biomarkers Prev (2007) 1.73